PHILADELPHIA CHROMOSOME NEGATIVE ALL
Clinical trials for PHILADELPHIA CHROMOSOME NEGATIVE ALL explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE ALL trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME NEGATIVE ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients after other treatments fail
Disease control Recruiting nowThis study is testing a combination of several drugs to try to get relapsed or treatment-resistant acute lymphoblastic leukemia (ALL) back under control. The goal is to achieve a strong response so patients can then receive a potentially curative stem cell transplant. It is for a…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New frontline attack on leukemia: CAR-T cells join chemotherapy
Disease control Recruiting nowThis study is testing a new treatment approach for adults newly diagnosed with a type of acute lymphoblastic leukemia (ALL). It combines standard chemotherapy with an immunotherapy called CAR-T cells, given after the initial chemo to help keep the cancer in remission. The goal is…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC